Understanding Clinical Innovation

Here’s how clinical innovation translates to a new drug’s success:

Chronic Disease Insights

Featured
Using Equinox Drivers Charts to Understand Fabhalta's Success in PNH
Chronic Diseases
Using Equinox Drivers Charts to Understand Fabhalta's Success in PNH
Chronic Diseases
Read More →
Chronic Diseases
Suzetrigine drivers.jpg
Chronic Diseases
Journavx, a vast improvement over opioids in moderate acute pain
Chronic Diseases
Read More →
Chronic Diseases
Xolair-Figure JPG.jpg
Chronic Diseases
Xolair for food allergies: effective therapy at a high price
Chronic Diseases
Read More →
Chronic Diseases
Leqembi-Figure.jpg
Chronic Diseases
Monoclonal antibodies for Alzheimer’s disease: questionable clinical benefit at a high price
Chronic Diseases
Read More →
Chronic Diseases
Evrysdi-figure.jpg
Chronic Diseases
Evrysdi: A Potential Game-Changer for SMA Type 1 Patients
Chronic Diseases
Read More →
Chronic Diseases
Risperidone-vs.-Ulatorant.jpg
Chronic Diseases
Prospects for ulotaront in schizophrenia
Chronic Diseases
Read More →
Chronic Diseases
Drivers.JPG
Chronic Diseases
Trikafta: A Major Step Forward for Cystic Fibrosis Patients
Chronic Diseases
Read More →
Chronic Diseases
Radicava: Not Innovative Enough to Sustain Strong Start
Chronic Diseases
Radicava: Not Innovative Enough to Sustain Strong Start
Chronic Diseases
Read More →
Chronic Diseases
Capture.JPG
Chronic Diseases
Hemlibra: A Strong Leader in Hemophilia A
Chronic Diseases
Read More →
Chronic Diseases
Capture.JPG
Chronic Diseases
Oral semaglutide: A game changer in type 2 diabetes
Chronic Diseases
Read More →
Chronic Diseases
Chronic Diseases
Tymlos: A new force in the osteoporosis market
Chronic Diseases
Read More →
Chronic Diseases
Capture.JPG
Chronic Diseases
Xeljanz: Is ulcerative colitis finally the place for JAKs to shine?
Chronic Diseases
Read More →
Chronic Diseases
MS 1.JPG
Chronic Diseases
Gilenya, Aubagio, and Tecfidera in Multiple Sclerosis
Chronic Diseases
Read More →
Chronic Diseases
jardiance.jpg
Chronic Diseases
Jardiance: New outcomes data in type 2 diabetes
Chronic Diseases
Read More →
Chronic Diseases
Chronic Diseases
Brintellix: Another "me too" in major depression
Chronic Diseases
Read More →
Chronic Diseases
Chronic Diseases
Pradaxa: Stroke prevention in atrial fibrillation
Chronic Diseases
Read More →
Chronic Diseases
Chronic Diseases
Stelara: Exceeding expectations in psoriasis
Chronic Diseases
Read More →
Chronic Diseases
Chronic Diseases
Pristiq: no innovation in major depressive disorder
Chronic Diseases
Read More →
Chronic Diseases
Chronic Diseases
Benlysta in SLE: A cautionary tale
Chronic Diseases
Read More →
Chronic Diseases